Arcadia Biosciences, Inc. (RKDA) › Cost of RevenueArcadia Biosciences, Inc. (RKDA) — Cost of RevenueAnnual figures by period end, from SEC filings.2020-12-31: $5.20M2021-12-31: $8.71M2022-12-31: $6.10M2023-12-31: $2.17M2024-12-31: $2.96M2025-12-31: $3.10M$3.10M2020-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$3.10M+4.6%2026-03-26From 2025-01-012024-12-31$2.96M+36.3%2026-03-26From 2024-01-012023-12-31$2.17M-64.4%2025-03-25From 2023-01-012022-12-31$6.10M-29.9%2024-03-28From 2022-01-012021-12-31$8.71M+67.5%2023-03-30From 2021-01-012020-12-31$5.20M—2022-03-31From 2020-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)